Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Turiello, Roberta; Capone, Mariaelena; Giannarelli, Diana; Morretta, Elva; Monti, Maria Chiara; Madonna, Gabriele; Mallardo, Domenico; Festino, Lucia; Azzaro, Rosa; Levesque, Mitchell P.; Imhof, Laurence; Weide, Benjamin; Amaral, Teresa; Chevrier, Marc; Sucker, Antje; Rutkowski, Piotr; Schadendorf, Dirk; Lebbe, Celeste; Luke, Jason John; Wistuba-Hamprecht, Kilian; Dummer, Reinhard; Pinto, Aldo; Morello, Silvana; Ascierto, Paolo A.

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Author:

Turiello, Roberta; Capone, Mariaelena; Giannarelli, Diana; Morretta, Elva; Monti, Maria Chiara; Madonna, Gabriele; Mallardo, Domenico; Festino, Lucia; Azzaro, Rosa; Levesque, Mitchell P.; Imhof, Laurence; Weide, Benjamin; Amaral, Teresa; Chevrier, Marc; Sucker, Antje; Rutkowski, Piotr; Schadendorf, Dirk; Lebbe, Celeste; Luke, Jason John; Wistuba-Hamprecht, Kilian; Dummer, Reinhard; Pinto, Aldo; Morello, Silvana; Ascierto, Paolo A.

Tübinger Autor(en):

Amaral, Teresa
Wistuba-Hamprecht, Kilian
Weide, Benjamin Matthias

Published in:

Journal For Immunotherapy of Cancer (2020), Bd. 8 (2), Article e001689

Verlagsangabe:

Bmj Publishing Group

Language:

English

Full text:

http://dx.doi.org/10.1136/jitc-2020-001689

ISSN:

2051-1426